NewsMV

ENvue Medical taps $50 million equity line as Series H preferred obligations expand

8/12/2026

A $50 million committed equity facility sits at the center of FEED's August 12 current report, with the draw window gated on SEC registration statement effectiveness and an embedded obligation to redirect 40 percent of every net dollar raised toward retiring Series X Preferred Stock.

The next confirmable milestone is Shareholder Approval, which separately governs a restructured Series H preferred commitment that now carries a $10 million minimum exercise floor.

The equity facility mechanics ENvue Medical, Inc. and an unnamed institutional investor signed a Common Shares Purchase Agreement on August 12, 2026.

Under the terms, the company can direct the investor to purchase shares priced at 90 percent of the lowest volume weighted average price across the three trading days preceding each applicable purchase date.